Universal definition of myocardial infarction

Heart

Volumn 95, Issue 3, 2009, Pages 247-249

  Hall, A S ^a,b   Barth, J H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Perinatal Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN; TROPONIN I; TROPONIN T;

ASSAY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; HEART INFARCTION; LABORATORY DIAGNOSIS; NORMAL VALUE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC; TROPONIN;

EID: 62149133457     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Thygesen K, Alpert JS, White HD et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
2. Anonymous. Heavens above! God could have created life on other planets, says Vatican. Daily Mail 15 May 2008.
3. White HD. Evolution of the definition of myocardial infarction: what are the implications of a new universal definition? Heart 2008;94:679-84.
4. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial Infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
5. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6.
6. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
7. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008;155:208-14.
8. Panteghini M, Gerhardt W, Apple FS, et al. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:175-9.
9. Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007;115:e352-5.
10. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers of acute coronary syndromes. Circulation 2007;115:e356-75.
11. Apple FS, Parvin CA, Buechler KF, et al. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005;51:2198-200.
12. Panteghini M, Pagani F, Yeo KT, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
13. IFCC. Values for the 99th percentile. Available at http://www.ifcc.org (accessed 11 Sep 2008).
14. Fitzmaurice TF, Brown C, Rifai N, et al. False increase in cardiac troponin I with heterophilic antibodies. Clin Chem 1998;44:2212-4.
15. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. J Am Coll Cardiol 2006;48:1-11.
16. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99-106.
17. Das R, Kilcullen N, Morrell C, Robinson MB, et al. EMMACE-2 (evaluation of methods and management of acute coronary events) Investigators. The British Cardiac Society Working Group definition of myocardial infarction: implications for practice. Heart 2006;92:21-6.